Mitochondrial Redox Modulation in Newly Diagnosed Type 2 Diabetes: A Randomized Controlled Trial Comparing Imeglimin vs. Metformin Monotherapy

NCT07436182 · clinicaltrials.gov ↗

PHASE4

Phase

NOT_YET_RECRUITING

Status

176

Enrollment

OTHER

Sponsor class

Conditions

Mitochondria
Metformin

Interventions

DRUG: Imeglimin
DRUG: Metformin 1000 mg Oral Tablet

Sponsor

Mansoura University